Press Releases for ENDP

Press Releases
Endo Pharmaceuticals Announces Resignation of Chief Operating Officer
Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
BenchmarkJournal.Com Free Analyst Review for QLGC, NEXM, GERN, ENDP, LOGI and ALXN
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Inc. Sign Licensing Agreement for Urocidin(TM)
Endo Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
Men with Low Testosterone See Multiple Doctors Before Being Diagnosed; Many Dissatisfied with Current Treatment Options
Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand
Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference
Endo Announces Compensation for New CFO Alan Levin
Endo Pharmaceuticals Appoints Alan G. Levin as Chief Financial Officer
Endo Pharmaceuticals Reports First Quarter 2009 Financial Results - Apr 29 2009 11:08AM
Endo Pharmaceuticals Reports First Quarter 2009 Financial Results - Apr 29 2009 8:00AM
Endo Pharmaceuticals Reports First Quarter 2009 Financial Results
Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show
Endo Pharmaceuticals to Announce First Quarter 2009 Financial Results on April 29, 2009
Zacks Releases New Stock Picks From the +21.7% Value Strategy: ADAM Inc., Big Lots, Endo Pharmaceuticals, Carrols Restaurant Group and Gray Television
Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors
Exercise Physiologist and Celebrity Trainer Bob Greene Leads National Campaign to Showcase Osteoarthritis Pain Management Techniques and New Treatment Approaches
Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals
Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
Endo Pharmaceuticals Extends Subsequent Offering Period for Indevus Shares Until 5:00 pm EDT on Wednesday, March 18, 2009
Burns & Levinson Guides Indevus Through Significant Pharmaceutical Transaction
Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals
Endo Licenses Novel Pain Therapy from Grunenthal
Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results
Endo Pharmaceuticals Appoints William Montague to Board of Directors
Endo and Penwest Announce Settlement of Opana(R) ER Litigation
Endo Pharmaceuticals Announces Research Collaborations to Develop Novel Pain Treatments and Discover Potential Cancer Treatments
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Endo Pharmaceuticals to Announce Fourth Quarter and 2008 Full-Year Financial Results on February 27, 2009
Zacks Analyst Blog Highlights: Sohu.Com, Inc., Priceline.Com, Dollar Financial Corp., Indevus Pharmaceuticals and Endo Pharmaceuticals.
Endo Pharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
BenchmarkJournal.Com (Complimentary) Analyst Review for IDEV, AMED, ENDP and CIEN
Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals
Endo Announces Resignation of Board Member
Endo Pharmaceuticals Announces Acceptance of UBS AG Settlement Offer Relating to Auction Rate Securities
Endo Pharmaceuticals Reports Strong Third Quarter Financial Results
Endo Pharmaceuticals to Hold Conference Call and Webcast on Third Quarter 2008 Financial Results
Endo Pharmaceuticals Announces Resignation of Chief Financial Officer
Endo Pharmaceuticals Appoints Dr. Sandeep Gupta, Senior Vice President, Discovery and Early Development
Endo Pharmaceuticals Reports Strong Second Quarter Financial Results
Endo Pharmaceuticals to Hold Conference Call and Webcast on Second Quarter 2008 Financial Results
Endo Pharmaceuticals Appoints Blaine T. Davis as Vice President, Investor Relations and Corporate Communications - May 27 2008 1:02AM
LPGA Tour Pro Diana D'Alessio Takes Swing at Menstrual Migraines - May 27 2008 12:54AM
New Analyst Reports for NOVA BIOSOURCE FUELS INC, ENDO PHARMACEUTICALS HOLDINGS INC, HYDROGENICS CORPORATION, and PDL BIOPHARMA INC - May 27 2008 1:16AM
Endo Pharmaceuticals and the D.E. Shaw Group Agree to Settlement
Endo Pharmaceuticals Reports First Quarter Financial Results
Endo Pharmaceuticals to Hold Conference Call on First Quarter 2008 Financial Results
Endo Announces Executive Appointment
Endo Pharmaceuticals Holdings Inc. Prices Private Offering of Convertible Senior Subordinated Notes
Endo Pharmaceuticals Holdings Inc. Announces Stock Repurchase Program and Proposed Private Offering of Convertible Senior Subordinated Notes
Endo Pharmaceuticals Provides Updates on FROVA(R) and CHRONOGESIC(R) Clinical Development Programs